Information about this group of cancers that effect the lymph nodes and immune system.
Oct 13, 2011
Persistence, worsening seen in more than one third of long-term non-Hodgkin's lymphoma survivors
Jul 8, 2014
Drug designed to inhibit T cells from becoming cancerous
Jun 2, 2015
Ibrutinib, obinutuzumab slow progression of CLL, non-Hodgkin's lymphoma